Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos Gonzalez

Showing results (141-150 of 178) with videos related to

Pageof 18
Sort By:
Contemporary Clinical Trials|November 26, 2018
Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET)Rebecca A Shelby, Caroline S Dorfman, Hayden B Bosworth, et al.
The Journal of Molecular Diagnostics : JMD|August 27, 2014
Altered interphase fluorescence in situ hybridization profiles of chromosomes 4, 8q24, and 9q34 in pancreatic ductal adenocarcinoma are associated with a poorer patient outcomeMaría L Gutiérrez, Luis Muñoz-Bellvis, María E Sarasquete, et al.
Plos One|November 10, 2010
Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arraysJosé María Sayagués, Celia Fontanillo, María del Mar Abad, et al.
Cell Reports|February 3, 2022
Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA displayShiho Tanaka, C Anders Olson, Christopher O Barnes, et al.
European Journal of Haematology|May 31, 2012
Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutationIris Cordoba, Carlota Pegenaute, Tomás José González-López, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA DisplayShiho Tanaka, C Anders Olson, Christopher O Barnes, et al.
Blood|January 25, 2007
Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosisJavier Corral, David Hernandez-Espinosa, Jose Manual Soria, et al.
The Journal of Bone and Joint Surgery. American Volume|November 9, 2023
Non-Fusion Versus Fusion Surgery in Pediatric Idiopathic Scoliosis: What Trade-Offs in Outcomes Are Acceptable for the Patient and Family?A Noelle Larson, Michelle Claire Marks, Juan Marcos Gonzalez Sepulveda, et al.
Blood Advances|October 31, 2023
Preferences for potential benefits and risks for gene therapy in the treatment of sickle cell diseaseJuan Marcos Gonzalez Sepulveda, Jui-Chen Yang, Shelby D Reed, et al.
The American Journal of Pathology|July 24, 2003
TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorderMargarida Lima, Julia Almeida, Maria Dos Anjos Teixeira, et al.
Pageof 18

Showing results (141-150 of 178) with videos related to

Sort By:
Pageof 18
Contemporary Clinical Trials|November 26, 2018
Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET)Rebecca A Shelby, Caroline S Dorfman, Hayden B Bosworth, et al.
The Journal of Molecular Diagnostics : JMD|August 27, 2014
Altered interphase fluorescence in situ hybridization profiles of chromosomes 4, 8q24, and 9q34 in pancreatic ductal adenocarcinoma are associated with a poorer patient outcomeMaría L Gutiérrez, Luis Muñoz-Bellvis, María E Sarasquete, et al.
Plos One|November 10, 2010
Mapping of genetic abnormalities of primary tumours from metastatic CRC by high-resolution SNP arraysJosé María Sayagués, Celia Fontanillo, María del Mar Abad, et al.
Cell Reports|February 3, 2022
Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA displayShiho Tanaka, C Anders Olson, Christopher O Barnes, et al.
European Journal of Haematology|May 31, 2012
Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutationIris Cordoba, Carlota Pegenaute, Tomás José González-López, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA DisplayShiho Tanaka, C Anders Olson, Christopher O Barnes, et al.
Blood|January 25, 2007
Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosisJavier Corral, David Hernandez-Espinosa, Jose Manual Soria, et al.
The Journal of Bone and Joint Surgery. American Volume|November 9, 2023
Non-Fusion Versus Fusion Surgery in Pediatric Idiopathic Scoliosis: What Trade-Offs in Outcomes Are Acceptable for the Patient and Family?A Noelle Larson, Michelle Claire Marks, Juan Marcos Gonzalez Sepulveda, et al.
Blood Advances|October 31, 2023
Preferences for potential benefits and risks for gene therapy in the treatment of sickle cell diseaseJuan Marcos Gonzalez Sepulveda, Jui-Chen Yang, Shelby D Reed, et al.
The American Journal of Pathology|July 24, 2003
TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorderMargarida Lima, Julia Almeida, Maria Dos Anjos Teixeira, et al.
Pageof 18